{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T03:35:14Z","timestamp":1793158514781,"version":"4.5.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T00:00:00Z","timestamp":1779926400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T00:00:00Z","timestamp":1779926400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Neurol Belg"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1007\/s13760-026-03092-y","type":"journal-article","created":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T14:23:34Z","timestamp":1779978214000},"page":"1573-1583","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Psychological resilience predicts medication adherence in multiple sclerosis"],"prefix":"10.1007","volume":"126","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-0538-1511","authenticated-orcid":false,"given":"Elif Y\u0131ld\u0131ran","family":"Teken","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0414-3343","authenticated-orcid":false,"given":"Tahir","family":"Teken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6282-6789","authenticated-orcid":false,"given":"Bet\u00fcl","family":"Bakay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5783-8061","authenticated-orcid":false,"given":"Ali Ulvi","family":"Uca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8864-2942","authenticated-orcid":false,"given":"Hasan","family":"Bakay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,28]]},"reference":[{"key":"3092_CR1","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1111\/ENE.13819","volume":"26","author":"R Dobson","year":"2019","unstructured":"Dobson R, Giovannoni G (2019) Multiple sclerosis - a review. Eur J Neurol 26:27\u201340. https:\/\/doi.org\/10.1111\/ENE.13819","journal-title":"Eur J Neurol"},{"key":"3092_CR2","doi-asserted-by":"publisher","first-page":"1816","DOI":"10.1177\/1352458520970841","volume":"26","author":"C Walton","year":"2020","unstructured":"Walton C, King R, Rechtman L, Kaye W, Leray E, Marrie RA, Robertson N, La Rocca N, Uitdehaag B, van der Mei I, Wallin M, Helme A, Angood Napier C, Rijke N, Baneke P (2020) Rising prevalence of multiple sclerosis worldwide: insights from the atlas of MS, third edition. Mult Scler 26:1816\u20131821. https:\/\/doi.org\/10.1177\/1352458520970841","journal-title":"Mult Scler"},{"key":"3092_CR3","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1191\/1352458503MS914OA","volume":"9","author":"M Eriksson","year":"2003","unstructured":"Eriksson M, Andersen O, Runmarker B (2003) Long-term follow up of patients with clinically isolated syndromes, relapsing-remitting and secondary progressive multiple sclerosis. Mult Scler 9:260\u2013274. https:\/\/doi.org\/10.1191\/1352458503MS914OA","journal-title":"Mult Scler"},{"key":"3092_CR4","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1097\/01.WCO.0000073928.19076.84","volume":"16","author":"JA Bobholz","year":"2003","unstructured":"Bobholz JA, Rao SM (2003) Cognitive dysfunction in multiple sclerosis: a review of recent developments. Curr Opin Neurol 16:283\u2013288. https:\/\/doi.org\/10.1097\/01.WCO.0000073928.19076.84","journal-title":"Curr Opin Neurol"},{"key":"3092_CR5","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1212\/WNL.0000000000000013","volume":"82","author":"SL Minden","year":"2014","unstructured":"Minden SL, Feinstein A, Kalb RC, Miller D, Mohr DC, Patten SB, Bever C, Schiffer RB, Gronseth GS, Narayanaswami P (2014) Evidence-based guideline: assessment and management of psychiatric disorders in individuals with MS: report of the guideline development subcommittee of the american academy of neurology. Neurology 82:174\u2013181. https:\/\/doi.org\/10.1212\/WNL.0000000000000013","journal-title":"Neurology"},{"key":"3092_CR6","first-page":"75","volume":"28","author":"Z Akp\u0131nar","year":"2010","unstructured":"Akp\u0131nar Z, G\u00fcnd\u00fcz ZB (2010) Multiple sclerosis and cognitive impairment. Selcuk Tip Derg 28:75\u201379","journal-title":"Selcuk Tip Derg"},{"key":"3092_CR7","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1111\/J.1365-2125.2012.04167.X","volume":"73","author":"B Vrijens","year":"2012","unstructured":"Vrijens B, De Geest S, Hughes DA, Przemyslaw K, Demonceau J, Ruppar T, Dobbels F, Fargher E, Morrison V, Lewek P, Matyjaszczyk M, Mshelia C, Clyne W, Aronson JK, Urquhart J (2012) A new taxonomy for describing and defining adherence to medications. Br J Clin Pharmacol 73:691\u2013705. https:\/\/doi.org\/10.1111\/J.1365-2125.2012.04167.X","journal-title":"Br J Clin Pharmacol"},{"key":"3092_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2014\/752318","volume":"2014","author":"G Di Battista","year":"2014","unstructured":"Di Battista G, Bertolotto A, Gasperini C, Ghezzi A, Maimone D, Solaro C (2014) Multiple Sclerosis State of the Art (SMART): a qualitative and quantitative analysis of therapy\u2019s adherence, hospital reliability\u2019s perception, and services provided quality. Mult Scler Int 2014:1\u20139. https:\/\/doi.org\/10.1155\/2014\/752318","journal-title":"Mult Scler Int"},{"key":"3092_CR9","doi-asserted-by":"publisher","DOI":"10.18553\/JMCP.2013.19.S1.S24","volume":"19","author":"J Menzin","year":"2013","unstructured":"Menzin J, Caon C, Nichols C, White LA, Friedman M, Pill MW (2013) Narrative review of the literature on adherence to disease-modifying therapies among patients with multiple sclerosis. J Manag Care Pharm 19:S1.S24. https:\/\/doi.org\/10.18553\/JMCP.2013.19.S1.S24","journal-title":"J Manag Care Pharm"},{"key":"3092_CR10","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.jns.2006.05.075","volume":"259","author":"M Clerico","year":"2007","unstructured":"Clerico M, Barbero P, Contessa G, Ferrero C, Durelli L (2007) Adherence to interferon-beta treatment and results of therapy switching. J Neurol Sci 259:104\u2013108. https:\/\/doi.org\/10.1016\/j.jns.2006.05.075","journal-title":"J Neurol Sci"},{"key":"3092_CR11","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1097\/01376517-200606000-00005","volume":"38","author":"D Cox","year":"2006","unstructured":"Cox D, Stone J (2006) Managing self-injection difficulties in patients with relapsing-remitting multiple sclerosis. J Neurosci Nurs 38:167\u2013171. https:\/\/doi.org\/10.1097\/01376517-200606000-00005","journal-title":"J Neurosci Nurs"},{"key":"3092_CR12","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1111\/J.1468-1331.2010.03110.X","volume":"18","author":"V Devonshire","year":"2011","unstructured":"Devonshire V, Lapierre Y, Macdonell R, Ramo-Tello C, Patti F, Fontoura P, Suchet L, Hyde R, Balla I, Frohman EM, Kieseier BC (2011) The Global Adherence Project (GAP): a multicenter observational study on adherence to disease-modifying therapies in patients with relapsing-remitting multiple sclerosis. Eur J Neurol 18:69\u201377. https:\/\/doi.org\/10.1111\/J.1468-1331.2010.03110.X","journal-title":"Eur J Neurol"},{"key":"3092_CR13","doi-asserted-by":"publisher","first-page":"261","DOI":"10.2147\/PPA.S187983","volume":"13","author":"R Morillo Verdugo","year":"2019","unstructured":"Morillo Verdugo R, Herr\u00e1iz ER, Del Olmo RF, Bonet MR, Garc\u00eda MV (2019) Adherence to disease-modifying treatments in patients with multiple sclerosis in Spain. Patient Prefer Adherence 13:261\u2013272. https:\/\/doi.org\/10.2147\/PPA.S187983","journal-title":"Patient Prefer Adherence"},{"key":"3092_CR14","doi-asserted-by":"publisher","first-page":"55","DOI":"10.2147\/PPA.S118107","volume":"11","author":"M Munsell","year":"2016","unstructured":"Munsell M, Frean M, Menzin J, Phillips AL (2016) An evaluation of adherence in patients with multiple sclerosis newly initiating treatment with a self-injectable or an oral disease-modifying drug. Patient Prefer Adherence 11:55\u201362. https:\/\/doi.org\/10.2147\/PPA.S118107","journal-title":"Patient Prefer Adherence"},{"key":"3092_CR15","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1177\/1352458506071161","volume":"13","author":"M Korostil","year":"2007","unstructured":"Korostil M, Feinstein A (2007) Anxiety disorders and their clinical correlates in multiple sclerosis patients. Mult Scler 13:67\u201372. https:\/\/doi.org\/10.1177\/1352458506071161","journal-title":"Mult Scler"},{"key":"3092_CR16","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1037\/0022-3514.48.1.150","volume":"48","author":"S Folkman","year":"1985","unstructured":"Folkman S, Lazarus RS (1985) If it changes it must be a process: study of emotion and coping during three stages of a college examination. J Pers Soc Psychol 48:150\u2013170","journal-title":"J Pers Soc Psychol"},{"key":"3092_CR17","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1177\/1352458506071170","volume":"13","author":"SR Montel","year":"2007","unstructured":"Montel SR, Bungener C (2007) Coping and quality of life in one hundred and thirty five subjects with multiple sclerosis. Mult Scler 13:393\u2013401. https:\/\/doi.org\/10.1177\/1352458506071170","journal-title":"Mult Scler"},{"key":"3092_CR18","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1111\/JFTR.12255","volume":"10","author":"AS Masten","year":"2018","unstructured":"Masten AS (2018) Resilience theory and research on children and families: past, present, and promise. J Fam Theory Rev 10:12\u201331. https:\/\/doi.org\/10.1111\/JFTR.12255","journal-title":"J Fam Theory Rev"},{"key":"3092_CR19","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1002\/WPS.20591","volume":"18","author":"AS Masten","year":"2019","unstructured":"Masten AS (2019) Resilience from a developmental systems perspective. World Psychiatry 18:101\u2013102. https:\/\/doi.org\/10.1002\/WPS.20591","journal-title":"World Psychiatry"},{"key":"3092_CR20","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1111\/BCP.14193","volume":"86","author":"AHY Chan","year":"2020","unstructured":"Chan AHY, Horne R, Hankins M, Chisari C (2020) The medication adherence report scale: a measurement tool for eliciting patients\u2019 reports of nonadherence. Br J Clin Pharmacol 86:1281\u20131288. https:\/\/doi.org\/10.1111\/BCP.14193","journal-title":"Br J Clin Pharmacol"},{"key":"3092_CR21","doi-asserted-by":"publisher","first-page":"52","DOI":"10.26650\/IUITFD.413637","volume":"82","author":"E Temelo\u01e7lu \u015een","year":"2019","unstructured":"Temelo\u01e7lu \u015een E, Sertel Berk \u00d6, Sindel D (2019) The validity and reliability study of the turkish adaptation of medical adherence report scale. Istanbul Tip Fak Derg 82:52\u201361. https:\/\/doi.org\/10.26650\/IUITFD.413637","journal-title":"Istanbul Tip Fak Derg"},{"key":"3092_CR22","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1002\/DA.10113","volume":"18","author":"KM Connor","year":"2003","unstructured":"Connor KM, Davidson JRT (2003) Development of a new resilience scale: the connor-davidson resilience scale (CD-RISC). Depress Anxiety 18:76\u201382. https:\/\/doi.org\/10.1002\/DA.10113","journal-title":"Depress Anxiety"},{"key":"3092_CR23","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1016\/j.psychres.2009.09.012","volume":"179","author":"\u00d6 Karairmak","year":"2010","unstructured":"Karairmak \u00d6 (2010) Establishing the psychometric qualities of the connor-davidson resilience scale (CD-RISC) using exploratory and confirmatory factor analysis in a trauma survivor sample. Psychiatry Res 179:350\u2013356. https:\/\/doi.org\/10.1016\/j.psychres.2009.09.012","journal-title":"Psychiatry Res"},{"key":"3092_CR24","doi-asserted-by":"publisher","DOI":"10.1037\/T01004-000","author":"SH Lovibond","year":"2011","unstructured":"Lovibond SH, Lovibond PF (2011) Depression anxiety stress scales. PsycTESTS Dataset. https:\/\/doi.org\/10.1037\/T01004-000","journal-title":"PsycTESTS Dataset"},{"key":"3092_CR25","doi-asserted-by":"publisher","DOI":"10.5455\/JCBPR.274847","author":"H Sari\u00e7am","year":"2018","unstructured":"Sari\u00e7am H (2018) The psychometric properties of turkish version of depression anxiety stress scale-21 (DASS-21) in health control and clinical samples. JCBPR. https:\/\/doi.org\/10.5455\/JCBPR.274847","journal-title":"JCBPR."},{"key":"3092_CR26","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1037\/0022-3514.56.2.267","volume":"56","author":"CS Carver","year":"1989","unstructured":"Carver CS, Scheier MF, Weintraub JK (1989) Assessing coping strategies: a theoretically based approach. J Pers Soc Psychol 56:267\u2013283","journal-title":"J Pers Soc Psychol"},{"key":"3092_CR27","first-page":"221","volume":"6","author":"MY A\u011farg\u00fcn","year":"2005","unstructured":"A\u011farg\u00fcn MY, Be\u015firo\u011flu L, K\u0131ran \u00dcK, \u00d6zer \u00d6A, Kara H (2005) COPE (Ba\u015fa \u00e7\u0131kma tutumlar\u0131n\u0131 de\u011ferlendirme \u00f6l\u00e7e\u011fi): Psikometrik \u00f6zelliklere ili\u015fkin bir \u00f6n \u00e7al\u0131\u015fma. Anadolu Psikiyatri Derg 6:221\u2013226","journal-title":"Anadolu Psikiyatri Derg"},{"key":"3092_CR28","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1177\/1352458507080733","volume":"14","author":"MC Simeoni","year":"2008","unstructured":"Simeoni MC, Auquier P, Fernandez O, Flachenecker P, Stecchi S, Constantinescu CS, Idiman E, Boyko A, Beiske AG, Vollmer T, Triantafyllou N, O\u2019Connor P, Barak Y, Biermann L, Cristiano E, Atweh S, Patrick DL, Robitail S, Ammoury N, Beresniak A, Pelletier J (2008) Validation of the multiple sclerosis international quality of life questionnaire. Mult Scler 14:219\u2013230. https:\/\/doi.org\/10.1177\/1352458507080733","journal-title":"Mult Scler"},{"key":"3092_CR29","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1212\/WNL.33.11.1444","volume":"33","author":"JF Kurtzke","year":"1983","unstructured":"Kurtzke JF (1983) Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 33:1444\u20131452. https:\/\/doi.org\/10.1212\/WNL.33.11.1444","journal-title":"Neurology"},{"key":"3092_CR30","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2377-14-58","author":"S Meyer-Moock","year":"2014","unstructured":"Meyer-Moock S, Feng YS, Maeurer M, Dippel FW, Kohlmann T (2014) Systematic literature review and validity evaluation of the expanded disability status scale (EDSS) and the multiple sclerosis functional composite (MSFC) in patients with multiple sclerosis. BMC Neurol. https:\/\/doi.org\/10.1186\/1471-2377-14-58","journal-title":"BMC Neurol"},{"key":"3092_CR31","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1177\/0163278710361924","volume":"33","author":"N Horvat","year":"2010","unstructured":"Horvat N, Kos M (2010) Development and initial validation of a patient satisfaction with pharmacy performance questionnaire (PSPP-Q). Eval Health Prof 33:197\u2013215. https:\/\/doi.org\/10.1177\/0163278710361924","journal-title":"Eval Health Prof"},{"key":"3092_CR32","doi-asserted-by":"publisher","first-page":"89","DOI":"10.2165\/11533330-000000000-00000","volume":"30","author":"SC Steinberg","year":"2010","unstructured":"Steinberg SC, Faris RJ, Chang CF, Chan A, Tankersley MA (2010) Impact of adherence to interferons in the treatment of multiple sclerosis: a non-experimental, retrospective, cohort study. Clin Drug Investig 30:89\u2013100. https:\/\/doi.org\/10.2165\/11533330-000000000-00000","journal-title":"Clin Drug Investig"},{"key":"3092_CR33","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1177\/070674371105600504","volume":"56","author":"H Herrman","year":"2011","unstructured":"Herrman H, Stewart DE, Diaz-Granados N, Berger EL, Jackson B, Yuen T (2011) What is resilience? Can J Psychiatry 56:258\u2013265. https:\/\/doi.org\/10.1177\/070674371105600504","journal-title":"Can J Psychiatry"},{"key":"3092_CR34","doi-asserted-by":"publisher","first-page":"36","DOI":"10.7224\/1537-2073.2011-038","volume":"15","author":"G Remington","year":"2013","unstructured":"Remington G, Rodriguez Y, Logan D, Williamson C, Treadaway K (2013) Facilitating medication adherence in patients with multiple sclerosis. Int J MS Care 15:36\u201345. https:\/\/doi.org\/10.7224\/1537-2073.2011-038","journal-title":"Int J MS Care"},{"key":"3092_CR35","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.msard.2015.12.003","volume":"6","author":"N Farran","year":"2016","unstructured":"Farran N, Ammar D, Darwish H (2016) Quality of life and coping strategies in lebanese multiple sclerosis patients: a pilot study. Mult Scler Relat Disord 6:21\u201327. https:\/\/doi.org\/10.1016\/j.msard.2015.12.003","journal-title":"Mult Scler Relat Disord"},{"key":"3092_CR36","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.msard.2018.06.001","volume":"25","author":"ALH Ledesma","year":"2018","unstructured":"Ledesma ALH, M\u00e9ndez AJR, Vidal LSG, Cruz GT, Garc\u00eda-Sol\u00eds P, Esquivel FdeJD (2018) Coping strategies and quality of life in Mexican multiple sclerosis patients: physical, psychological and social factors relationship. Mult Scler Relat Disord 25:122\u2013127. https:\/\/doi.org\/10.1016\/j.msard.2018.06.001","journal-title":"Mult Scler Relat Disord"},{"key":"3092_CR37","first-page":"155","volume":"63","author":"ME Garay-Sevilla","year":"2011","unstructured":"Garay-Sevilla ME, Porras JS, Malacara JM (2011) Coping strategies and adherence to treatment in patients with type 2 diabetes mellitus. Rev Invest Clin 63:155\u2013161","journal-title":"Rev Invest Clin"},{"key":"3092_CR38","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1097\/JNN.0000000000000395","volume":"50","author":"\u00d6 Erbay","year":"2018","unstructured":"Erbay \u00d6, Usta Ye\u015filbalkan \u00d6, Y\u00fcceyar N (2018) Factors affecting the adherence to disease-modifying therapy in patients with multiple sclerosis. J Neurosci Nurs 50:291\u2013297. https:\/\/doi.org\/10.1097\/JNN.0000000000000395","journal-title":"J Neurosci Nurs"},{"key":"3092_CR39","doi-asserted-by":"publisher","DOI":"10.24926\/IIP.V13I3.4991","volume":"13","author":"A Chatoo","year":"2022","unstructured":"Chatoo A, Lee S (2022) Association of coping strategies and medication adherence: a systematic review. Innov Pharm 13:10. https:\/\/doi.org\/10.24926\/IIP.V13I3.4991","journal-title":"Innov Pharm"}],"container-title":["Acta Neurologica Belgica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13760-026-03092-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13760-026-03092-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13760-026-03092-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T02:59:00Z","timestamp":1793156340000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13760-026-03092-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,28]]},"references-count":39,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["3092"],"URL":"https:\/\/doi.org\/10.1007\/s13760-026-03092-y","relation":{},"ISSN":["0300-9009","2240-2993"],"issn-type":[{"value":"0300-9009","type":"print"},{"value":"2240-2993","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,28]]},"assertion":[{"value":"12 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Written informed consent was obtained from all participants in the study.","order":2,"name":"Ethics","label":"Consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":3,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted in accordance with the Declaration of Helsinki for investigations involving human subjects and was approved by the Necmettin Erbakan University Ethics Committee for Non-Drug and Non-Medical Device Research (IRB Date\/Number: 2024\/4752).","order":4,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}}]}}